“…Given the rarity of ocular melanoma among pediatric patients (Singh et al, 2000), referral for general ophthalmic evaluation in the setting of benign halo nevi is currently not recommended (Paller & Mancini, 2021). In the literature, improvement of benign halo nevi have been reported after treatment with topical calcineurin inhibitors (Hossain et al, 2013), topical Janus kinase inhibitors (Hu et al, 2018), dermabrasion (Awad et al, 2019), and narrow-band ultraviolet B phototherapy (Shah et al, 2019). In general, however, no treatment is necessary for halo nevi in pediatric patients (Saleem et al, 2019).…”